Experience of application of the interferon inducer in complex treatment of patients with community-acquired pneumonia
Military Medical Administration of Security Service of Ukraine, Central hospital
In the article an examination and treatment of 100 patients with no severe community-acquired pneumonia is presented. Particular attention is paid to the results of treatment with interferon inducer Tilorone (Lavomax). Analysis of the results of the study confirm that the use of the drug Lavomax in the treatment of patients with community acquired pneumonia of viral etiology can reduce the term manifestations of intoxication syndrome.